AzTrials
AzTrials

Gaining Skeletal Muscle Mass and StrengthNCT02222415

Exercise Training in Healthy Young Men

A study testing Exercise + Protein drink in people with Gaining Skeletal Muscle Mass and Strength, run by Maastricht University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Resistance type exercise training has been shown to be a potent stimulus to increase skeletal muscle mass and strength in healthy men. Furthermore, timed protein intake is also known to affect the muscle adaptive response following exercise. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
What is being tested?
Exercise + Protein drink
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
44 participants
Where
1 siteNetherlands
Study dates
Oct 2011to Feb 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Healthy
  • Age between 18 and 30 years
  • BMI between 18.5 and 30 kg/m2
  • Recreationally active, performing sports on a non-competitive basis between 2 and 5 hours p/wk
  • Participants willing and able to give written informed consent and to understand, to participate and to comply with the biomedical research project requirements

Who cannot join

  • HbA1C level above 6.5%
  • Fasted blood glucose level above 7 mmol/L
  • Serum creatinine level beneath 60 or above 120 µmol/L
  • Participants with a recent history or current state of COPD
  • Participants with a recent history or current state of rheumatoid arthritis
  • Participants with a recent history or current state of musculoskeletal/orthopedic disorders
Show all 12Show fewer
  • Participants with a recent history or current state of renal disorder
  • Participants with a recent history or current state of cognitive impairment
  • Participants with orthopedic metal implants in the spine and/or upper/lower extremities
  • Participants with lactose intolerance and/or dairy protein allergy
  • Participants who are enrolled in an interventional biomedical research project or have received an investigational new drug or product with the last 30 days prior to screening.
  • Participants on medication, including anticoagulants

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University

    Maastricht, Limburg, 6229ER

Other trials in Netherlands

About this study

Official title: The Impact of Timed Protein Supplementation to Maximize the Skeletal Muscle Adaptive Response to Resistance Type Exercise Training in Healthy Young Men

Resistance type exercise training has been shown to be a potent stimulus to increase skeletal muscle mass and strength in healthy men. Furthermore, timed protein intake is also known to affect the muscle adaptive response following exercise. Whether timed protein intake could augment the increase in muscle fiber size and/or satellite cell content following long-term exercise intervention remains to be established.

We hypothesize that protein supplementation before sleep, on both training and non-training days, during a 12 week resistance training program further increases type II muscle fibre cross sectional area when compared to the placebo group.

Being tested
Exercise + Protein drink
Keywords
Muscle mass, Strength, Cross-sectional area, Protein

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise + Protein drinkDietary supplement

Study groups in NCT02222415
Study groupRoleWhat they receive
Training + placebo drinkPlacebo comparatorExercise + non-caloric placebo drink
Receives: Dietary Supplement: Exercise + Protein drink
Exercise + Protein drinkExperimentalexercise + Drink containing Protein, Carbohydrates and Fat
Receives: Dietary Supplement: Exercise + Protein drink

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Skeletal muscle fiber size

    Skeletal muscle fiber size will be assessed by muscle biopsy sampling before, during and after the 12 wks intervention period.

    Muscle fiber size will be expressed in µm2

    Measured: 12 weeks

Secondary outcomes (3)
  1. Quadriceps cross-sectional area

    Quadriceps cross-sectional area will be assessed by CT-scan before and after the 12 wks intervention period.

    Quadriceps cross-sectional area will be expressed in cm2

    Measured: 12 weeks

  2. Whole body en regional body composition

    Body composition (whole-body as well as regional) well be determined by DXA-scan performed before and after the 12 wks intervention period.

    Results will be expressed in kilograms

    Measured: 12 weeks

  3. 1RM strength

    Maximum muscle strength will be assessed before, during and after 12 wks of exercise training by means of a 1 rep max test and will be expressed in kilograms.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2014 (estimated)
  2. Study startOct 2011
  3. Primary completionFeb 2012
  4. Study completionFeb 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02222415
Sponsor's protocol ID
MEC 11-03-45
Status last verified
Aug 2014
First submitted
20 Aug 2014
Last updated
22 Aug 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Cermak NM, Res PT, de Groot LC, Saris WH, van Loon LJ. Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. Am J Clin Nutr. 2012 Dec;96(6):1454-64. doi: 10.3945/ajcn.112.037556. Epub 2012 Nov 7.

    PubMed 23134885
  • Res PT, Groen B, Pennings B, Beelen M, Wallis GA, Gijsen AP, Senden JM, VAN Loon LJ. Protein ingestion before sleep improves postexercise overnight recovery. Med Sci Sports Exerc. 2012 Aug;44(8):1560-9. doi: 10.1249/MSS.0b013e31824cc363.

    PubMed 22330017
  • Snijders T, Res PT, Smeets JS, van Vliet S, van Kranenburg J, Maase K, Kies AK, Verdijk LB, van Loon LJ. Protein Ingestion before Sleep Increases Muscle Mass and Strength Gains during Prolonged Resistance-Type Exercise Training in Healthy Young Men. J Nutr. 2015 Jun;145(6):1178-84. doi: 10.3945/jn.114.208371. Epub 2015 Apr 29.

    PubMed 25926415

Questions about this trial

What is this clinical trial studying?

A study testing Exercise + Protein drink in people with Gaining Skeletal Muscle Mass and Strength, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Aug 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Skeletal muscle fiber size (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02222415, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in